HomeKNSA • NASDAQ
add
Kiniksa Pharmaceuticals Internationl PLC
Previous close
$30.26
Day range
$30.04 - $32.15
Year range
$17.82 - $32.15
Market cap
2.37B USD
Avg Volume
920.86K
P/E ratio
778.48
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 156.80M | 44.34% |
Operating expense | 65.62M | -1.20% |
Net income | 17.83M | 556.29% |
Net profit margin | 11.37 | 415.83% |
Earnings per share | 0.23 | 483.33% |
EBITDA | 20.52M | 6,455.27% |
Effective tax rate | 22.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 307.78M | 40.70% |
Total assets | 661.15M | 21.89% |
Total liabilities | 166.14M | 54.79% |
Total equity | 495.01M | — |
Shares outstanding | 74.11M | — |
Price to book | 4.52 | — |
Return on assets | 8.00% | — |
Return on capital | 10.37% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 17.83M | 556.29% |
Cash from operations | 28.09M | 443.54% |
Cash from investing | -3.88M | 91.70% |
Cash from financing | 10.70M | 6,110.11% |
Net change in cash | 34.90M | 183.49% |
Free cash flow | 17.04M | 515.30% |
About
Founded
2015
Website
Employees
315
